[Current opioid consumption among younger patients : A comparison between the years 2019 and 2023 in a large addiction clinic in Hamburg].

BACKGROUND

It remains unclear whether an opioid crisis similar to that in the United States can be expected in Germany. In September 2024, the federal government stated that it does not see any danger of this occurring in the country. Nevertheless, the number of drug-related deaths in 2023 reached an all-time high of 2227 victims, with opioids involved in 1626 of those cases. For a more comprehensive assessment, information from additional settings may be helpful.

OBJECTIVES

This study aimed to analyze the quantitative development of inpatient treatment cases of younger patients with opioid addiction from a large addiction clinic in Hamburg, as well as their consumption patterns.

MATERIALS AND METHODS

Based on data stored in electronic patient records, a comparison was made of the relative proportions of inpatient patients treated for opioid addiction in the age groups "18-30 years" vs. "≥ 31 years" between the years 2019 and 2023 using chi-square tests. Additionally, the substances consumed were analyzed.

RESULTS

A significant increase in the relative proportion of young opioid-dependent patients was observed, rising from 17.2% in 2019 to 27.5% in 2023 (p < 0.001). Heroin remained the most commonly consumed substance, consistently inhaled or taken nasally. The use of oxycodone increased significantly. Additionally, a significant increase in pregabalin consumption was noted.

CONCLUSIONS

Although the collected data may not be representative of Germany as a whole, our study suggests a growing issue with opioid addiction. Possible causes may include psychological stress, potentially influenced by the aftermath of the COVID-19 pandemic. The results highlight the need for more comprehensive treatment options and preventive measures.